The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lenalidomide Clonmel 15 mg hard capsules



Clonmel Healthcare LtdPA0126/320/005

Main Information

Trade NameLenalidomide Clonmel 15 mg hard capsules
Active SubstancesLenalidomide
Dosage FormCapsule, hard
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/320/005

Group Information

ATC CodeL04AX04 lenalidomide

Status

License statusAuthorised
Licence Issued30/04/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back